Watchlist Price Alert

Protagonist Therapeutics ... (PTGX)

NASDAQ: PTGX · Real-Time Price · USD

43.79

-0.48 (-1.08%)

At close: May 14, 2025, 3:59 PM

42.12

-3.81%

Pre-market: May 15, 2025, 04:53 AM EDT

Protagonist Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	97.25M	186.73M	125.74M	123.67M	117.36M	33.01M	82.23M	106.03M	21.08M
Short-Term Investments	321.66M	154.89M	111.61M	203.24M	188.45M	100.01M	46.62M	37.97M	56.52M
Long-Term Investments	140.25M	n/a	225K	225K	2M	450K	450K	11.46M	10.15M
Other Long-Term Assets	225K	225K	5.72M	n/a	450K	450K	450K	450K	34K
Receivables	168.49M	10.33M	52K	1.57M	2.43M	6.75M	6.51M	3.22M	2.24M
Inventory	n/a	n/a	-94K	8.5M	3.98M	4.79M	2.14M	-8.75M	-7.65M
Other Current Assets	n/a	n/a	n/a	3.77M	1.41M	754K	1.93M	1.49M	508K
Total Current Assets	591.64M	355.58M	237.35M	340.74M	315.61M	145.31M	137.5M	150.95M	83.24M
Property-Plant & Equipment	12.61M	2.15M	4.63M	6.73M	6.41M	7.72M	861K	879K	562K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	-1.04M	-450K	-450K	n/a	n/a
Total Long-Term Assets	153.08M	2.37M	10.57M	6.96M	8.86M	9.61M	1.97M	12.79M	10.75M
Total Assets	744.73M	357.95M	247.93M	347.69M	324.47M	154.92M	139.47M	163.73M	93.99M
Account Payables	1.61M	772K	3.64M	1.6M	3.08M	2.79M	5.71M	1.26M	1.16M
Deferred Revenue	18.89M	n/a	69K	1.6M	14.48M	41.53M	8.22M	31.75M	n/a
Short-Term Debt	510K	n/a	2.52M	2.2M	1.46M	1.26M	n/a	n/a	n/a
Other Current Liabilities	23.69M	6.79M	17.54M	28.88M	13.28M	7.61M	9.5M	6.83M	120K
Total Current Liabilities	47.4M	21.27M	31.18M	44.02M	40.24M	35.41M	26.16M	42.55M	6.43M
Long-Term Debt	10.36M	n/a	n/a	n/a	n/a	9.79M	n/a	n/a	n/a
Other Long-Term Liabilities	11.68M	-221K	n/a	n/a	121K	n/a	799K	547K	n/a
Total Long-Term Liabilities	22.03M	n/a	784.68M	3.66M	4.62M	39.55M	799K	547K	n/a
Total Liabilities	69.43M	21.27M	784.68M	47.67M	44.86M	74.95M	26.96M	43.1M	6.43M
Total Debt	10.87M	1.14M	3.66M	5.86M	5.96M	17.01M	n/a	n/a	n/a
Common Stock	1K	1K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-340.52M	-615.71M	-536.75M	-409.36M	-283.81M	-217.66M	-140.47M	-101.55M	-64.59M
Comprehensive Income	-82K	-105K	-359K	-299K	28K	-221K	-233K	-6K	-245K
Shareholders Equity	675.29M	336.68M	-536.75M	-409.36M	-283.81M	-217.66M	-140.47M	-101.55M	-64.59M
Total Investments	461.92M	154.89M	111.61M	203.24M	190.45M	100.01M	46.62M	49.43M	66.67M